Actis is a London based investor in energy and infrastructure that builds renewable power and road platforms in India. Its main Indian platform is BluPine Energy, a utility scale renewables developer.
Ownership and structure
Actis invests in India through its private funds, which build and own platforms such as BluPine Energy and a portfolio of hybrid annuity road assets.
What India does for Actis
India is a core market for Actis infrastructure funds, which build renewable energy and road platforms in the country and sell them once they reach scale.
Investment and deals
In October 2021 Actis committed US$850 million to Indian sustainable infrastructure over five years from its Actis Energy 5 fund. In 2022 it backed its new platform BluPine Energy with up to US$800 million.
Actis's India business
Actis set up BluPine Energy in 2022 with backing of up to US$800 million. BluPine Energy targets 4 GW of utility scale solar, wind and storage projects.
In 2024 Actis acquired a portfolio of operational hybrid annuity model road assets in India.
Key moves in India
- 2013: Actis invested US$48 million in Indian drug maker Symbiotec Pharmalab, exiting in 2018.
- 2017: Actis established the renewable energy platform Sprng Energy.
- 2021: It committed US$850 million to Indian sustainable infrastructure projects over five years.
- 2022: Actis agreed in April to sell Sprng Energy to Shell for US$1.55 billion.
- 2022: It set up BluPine Energy with up to US$800 million to target 4 GW of solar, wind and storage.
- 2024: Actis acquired a portfolio of operational hybrid annuity model road assets in India.
Where it operates
Actis runs its India business from Mumbai.
At a glance
- Home country: United Kingdom
- Global headquarters: London
- Sector: Infrastructure & Data Centres
- Business: Infrastructure investment
- Role of India: Investment portfolio
- India head office: Mumbai
- India offices: Mumbai
- India headcount: Not available
© 2026 The Narrative Republic
See every foreign company we track in our Foreign Companies in India directory.
